Reliability and validity of French, German, Italian, Dutch, and UK English translations of the medical outcomes study HIV health survey

Medical Care

Volumn 37, Issue 9, 1999, Pages 908-925

  Scott Lennox, Jane A ^a   Wu, Albert W ^b   Boyer, J Gregory ^c   Ware Jr , John E ^d  

^a Piedmont Research Institute Inc   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Searle   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

Health related quality of life; HIV AIDS; MOS HIV; Psychometric validation; Translation validation

Indexed keywords

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CLASSIFICATION; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISEASE COURSE; EUROPE; FACTORIAL ANALYSIS; FEMALE; HEALTH STATUS; HEALTH SURVEY; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LANGUAGE; MALE; MULTICENTER STUDY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARD; TREATMENT OUTCOME; UNITED STATES;

ACTIVITIES OF DAILY LIVING; ADULT; CD4 LYMPHOCYTE COUNT; DISEASE PROGRESSION; EUROPE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HIV INFECTIONS; HUMANS; MALE; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TRANSLATING; TREATMENT OUTCOME; UNITED STATES;

EID: 0033194823     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-199909000-00007     Document Type: Review

References (38)

1. Hunt SM. Cross-cultural comparability of quality of life measures. Drug Info J 1993;27:395.
2. Bullinger M, Anderson R, Cella D, et al. Developing and evaluating cross-cultural instruments from minimum requirements to optimal models. Qual Life Res 1993;2:451-9.
3. Irvine SH, Wright DE, et al. Measuring quality of life across cultures: some cautions and prescriptions. Drug Info J 1994;28:55-62.
4. Herdman M, Fox-Rushby J, Badia X. Equivalence and the translation and adaption of health-related quality of life questionnaires. Qual Life Res 1997;6: 237-47.
5. Hui C, Triandis HC. Measurement in cross-cultural psychology: A revie and comparison of strategies. Cross Cultural Psychol 1985;16:131-52.
6. Hunt S, McKenna S. Cross-cultural comparability of quality of life measures. Brit J of Med Econ 1992;4:17-23.
7. Guyatt GH. The Philosophy of health-related quality of life translation. Qual Life Res 1993;2:461-5.
8. Aaronson NK, Acquadro C, Alonso J, et al. International quality of life assessment (IQOLA) project. Qual Life Res 1992;1:349.
9. Ware JE JR, Gandek BL, Keller SD, and the IQOLA Project Group. Evaluating instruments used cross-nationally: Methods from the IQOLA project. Chap. 71. In: Spilker b, ED. Quality of Life and Pharmacoeconomics in Clinical Trials. Ed. 2. Philadelphia, PA: Lippincott-Raven Publishers, 1996:681-92.
10. Leplège A, Bucquet D. Translation, linguistic validation and preliminary psychometric assessment of the SF-36 in French within the IQUOLA Project. Qual Life Res 1993;3:84.
11. Mathias SD, Fifer SK, Patrick DL. rapid translation of quality of life measures for international clinical trials: Avoiding errors in the minimalist approach. Qual of Life Res 1994;3:403-12.
12. Wu AW, Rubin HR, Mathews WC et al. A health status questionnnaire using 30 items from the medical outcomes study. Med Care 1991;29:786.
13. Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the Medical Outcomes Study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997;6:531-54.
14. Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity, and usefulness of the Medical Outcomes Study HIV Health Survey (MOS HIV). Qual Life Res 1997;6:481-93.
15. Revicki DA, Sorenson S, Wu AW. reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care 1998;36:126-37.
16. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist (HSCL): A self-report symptom inventory. Behav Sci 1974;19:1-15.
17. Volberding PA, Lagkos SW, Kock MA et al. Zidovudine in asymptomatic human immunodeficiency infection: A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990;322:941.
18. Acquadro C, Jambon B, Ellis D, Marquis P. Language and translation issues. Chap. 63. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Ed. 2. Philadelphia, PA: Lippincott-Raven Publishers, 1996:575-85.
19. Cella DF, Lloyd SR, Wright BD. Cross-cultural instrument equating: Current research and future directions. Chap. 73 In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials. Ed. 2. Philadelphia, PA: Lippincott-Raven Publishers, 1996:707-15.
20. Miller J, Slomczynski KM, Schoenberg RJ. Assessing comparability of measurement in cross-national research: Authoritarian-conservatism in different sociocultural settings. Soc Psych Q 1981;44:178.
21. Hays RD, Hayashi T, Carson S, Ware JE Jr. User's Guide for Multitrait Analysis Program (MAP) RAND NOTE N-2786-RC, Nov 1988.
22. SAS Version 6.12, SAS Institute. Cary, NC, 1996.
23. Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrika 1951;6:297-334.
24. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 health survey: Manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
25. McHorney CA, Ware JE, Rogers W, et al. The Validity and relative precision of MOS Short- and Long-Form health Status scales and Dartmouth COOP charts. Med Care 1992;30:253-63.
26. Scott-Lennox JA, McLaughlin-Miley CJ, Mauskopf JA. Impact of lamivudine and zidovudine therapy on quality of life (QOL). In: XI International Conference on AIDS, Vancouver, 1996.
27. th Conf on Retroviruses Opportun Infect 1997;31:298.
28. Lenderking WR, Testa MA, Latzenstein D, Hammer S. Measuring quality of life in early HIV disease: The modular approach. Qual Life Res 1997;6:515-30.
29. Peterman AH, Cella D, Mo F, McCain N. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHT) quality of life instrument. Qual Life Res 1997;6:572-84.
30. Safrin S, Finkelstein DM, Feinberg J et al. Comparison of three regimens for treatment of mild to moderate pneumocystis carinii pneumonia in patients with AIDS. Ann Intern Med 1996;124:792-802.
31. The SOCA Research Group. Combination foscarnet and gancylovir therapy vs. monotherapy for the treatment relapsed cytomegalovirus retinis in patients with AIDS. Arch Opthomal 1996:114.
32. Wu AW, Jacobson D, Berzon R et al. The effect of mode of administration on medical outcomes study health ratings and EuroQOL scores in AIDS. Qual Life Res 1997;6:3-10.
33. Carretero MD, Burgess AP, Soler P, Soler M, Catalan J. reliability and validity of an HIV-specific health related quality of life (QoL) measure for use with infecting drug users. AIDS 1996;10:1699-705.
34. Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL. Construct validites of the Quality of Well-Being Scale and the MOS-HIV-34 Health Survey for HIV-infected patients. Med Decis Making 1997;17:439-46.
35. Revicki DA, Wu AW, Murray MI. Change in clinical status, health status, and health utility outcomes in HIV-infected patients. Med Care 1995;33:173-82.
36. Burgess A, Dayer M, Catalan J, et al. The reliability and validity of two HIV-specific health-related quality of life measures: A preliminary analysis. AIDS 1994;7:1001-6.
37. Copfer AE, Ampel NM, Hughes TE et al. the use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison. Qual Life Res 1996;5:281-6.
38. Ganz PA, Schag CA, Kahn B, Petersen L. Assessing the quality of life in HIV infected persons: Clinical and descriptive information from studies with the HOPRES. Psychol Health 1994;9:93-110.